Hussman Strategic Advisors’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-15,600
Closed -$946K 319
2022
Q3
$946K Sell
15,600
-15,600
-50% -$493K 0.16% 209
2022
Q2
$847K Buy
31,200
+15,600
+100% +$456K 0.15% 218
2022
Q1
$570K Hold
15,600
0.11% 245
2021
Q4
$771K Buy
+15,600
New +$865K 0.17% 193

Other funds holding PRTA

Hussman Strategic Advisors's PRTA Position: Q4 2022 in Review

Hussman Strategic Advisors sold out of Prothena Corp (PRTA) in Q4 2022, closing a stake of 15,600 shares — an estimated $946K sold.

Hussman Strategic Advisors first reported a position in PRTA in Q4 2021 and held it in 4 quarters. The position peaked at $946K in Q3 2022. 201 funds tracked by Wall St. Rank hold PRTA as of Q4 2022.

  • Hussman Strategic Advisors reported no remaining Prothena Corp position as of Q4 2022 after selling out during the quarter.
  • Hussman Strategic Advisors sold 15,600 Prothena Corp shares in Q4 2022, an estimated $946K.
  • Hussman Strategic Advisors first reported a position in Prothena Corp in Q4 2021 and held it in 4 quarters.
  • Hussman Strategic Advisors's Prothena Corp position peaked at $946K in Q3 2022.
  • 201 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2022.

Based on Hussman Strategic Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.